Literature DB >> 16835691

Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity.

F Tribl1, K Marcus, G Bringmann, H E Meyer, M Gerlach, P Riederer.   

Abstract

Proteomics is a promising approach, which provides information about the expression of proteins and increasingly finds application in life science and disease research. Meanwhile, proteomics has proven to be applicable even on post mortem human brain tissue and has opened a new area in neuroproteomics. Thereby, neuroproteomics is usually employed to generate large protein profiles of brain tissue, which mostly reflect the expression of highly abundant proteins. As a complementary approach, the focus on sub-proteomes would enhance more specific insight into brain function. Sub-proteomes are accessible via several strategies, including affinity pull-down approaches, immunoprecipitation or subcellular fractionation. The extraordinary potential of subcellular proteomics to reveal even minute differences in the protein constitution of related cellular organelles is exemplified by a recent global description of neuromelanin granules from the human brain, which could be identified as pigmented lysosome-related organelles.

Entities:  

Mesh:

Year:  2006        PMID: 16835691     DOI: 10.1007/s00702-006-0513-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  103 in total

Review 1.  Large-gel 2-D electrophoresis.

Authors:  J Klose
Journal:  Methods Mol Biol       Date:  1999

Review 2.  Proteomics meets cell biology: the establishment of subcellular proteomes.

Authors:  E Jung; M Heller; J C Sanchez; D F Hochstrasser
Journal:  Electrophoresis       Date:  2000-10       Impact factor: 3.535

Review 3.  The application of mass spectrometry to membrane proteomics.

Authors:  Christine C Wu; John R Yates
Journal:  Nat Biotechnol       Date:  2003-03       Impact factor: 54.908

Review 4.  The benefits of microarrays as tools for studying neuropsychiatric disorders.

Authors:  Edna Grünblatt
Journal:  Drugs Today (Barc)       Date:  2004-02       Impact factor: 2.245

5.  A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle.

Authors:  Richard D Bagshaw; Don J Mahuran; John W Callahan
Journal:  Mol Cell Proteomics       Date:  2004-12-02       Impact factor: 5.911

Review 6.  DNA chip technology in brain banks: confronting a degrading world.

Authors:  Carlos Buesa; Tamara Maes; Francesca Subirada; Marta Barrachina; Isidro Ferrer
Journal:  J Neuropathol Exp Neurol       Date:  2004-10       Impact factor: 3.685

7.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

Review 8.  Application of proteomics technologies in the investigation of the brain.

Authors:  Michael Fountoulakis
Journal:  Mass Spectrom Rev       Date:  2004 Jul-Aug       Impact factor: 10.946

9.  Possible role of neuromelanin in the pathogenesis of Parkinson's disease.

Authors:  D M Mann; P O Yates
Journal:  Mech Ageing Dev       Date:  1983-02       Impact factor: 5.432

10.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

View more
  9 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

Review 2.  Proteomic studies on the development of the central nervous system and beyond.

Authors:  Chenggang Zhang
Journal:  Neurochem Res       Date:  2010-06-25       Impact factor: 3.996

Review 3.  Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.

Authors:  F Tribl; K Marcus; H E Meyer; G Bringmann; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

Review 4.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

5.  Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.

Authors:  Florian Tribl; Esther Asan; Thomas Arzberger; Thomas Tatschner; Elmar Langenfeld; Helmut E Meyer; Gerhard Bringmann; Peter Riederer; Manfred Gerlach; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

6.  Non-coding RNA as a trigger of neuropathologic disorder phenotypes in transgenic Drosophila.

Authors:  Elena Savvateeva-Popova; Andrej Popov; Abraham Grossman; Ekaterina Nikitina; Anna Medvedeva; Dmitry Molotkov; Nicholas Kamyshev; Konstantin Pyatkov; Olga Zatsepina; Natalya Schostak; Elena Zelentsova; Galina Pavlova; Dmitry Panteleev; Peter Riederer; Michail Evgen'ev
Journal:  J Neural Transm (Vienna)       Date:  2008-09-09       Impact factor: 3.575

7.  Proteomic screening of glutamatergic mouse brain synaptosomes isolated by fluorescence activated sorting.

Authors:  Christoph Biesemann; Mads Grønborg; Elisa Luquet; Sven P Wichert; Véronique Bernard; Simon R Bungers; Ben Cooper; Frédérique Varoqueaux; Liyi Li; Jennifer A Byrne; Henning Urlaub; Olaf Jahn; Nils Brose; Etienne Herzog
Journal:  EMBO J       Date:  2014-01-10       Impact factor: 11.598

Review 8.  Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.

Authors:  Anubhuti Dixit; Rachna Mehta; Abhishek Kumar Singh
Journal:  Cell Mol Neurobiol       Date:  2019-06-12       Impact factor: 5.046

Review 9.  Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.

Authors:  W Michael Caudle; Theo K Bammler; Yvonne Lin; Sheng Pan; Jing Zhang
Journal:  Expert Rev Neurother       Date:  2010-06       Impact factor: 4.618

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.